Empowering Health: Acute Psychological Effects of an Electromyostimulation-Whole-Body-Workout

July 27, 2021 updated by: Antonia Bendau, Charite University, Berlin, Germany

Empowering Health: Acute Psychological Effects of a Single Electromyostimulation-Whole-Body-Workout in Participants With Depression

The study investigates the acute psychological effects of a whole-body-workout using Electromyostimulation (EMS) in participants with depression and healthy individuals.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

EMS-whole-body-workouts are less time-consuming and effort-intensive but generate physical effects which are comparable to conventional strength training. Therefore EMS could lower the barrier to physical activity. The present study focusses on acute psychological effects of an EMS workout - especially with regard to the reduction of depressive symptoms. Physical activity is notably important for patients with depression and shows multiple positive psychological and physical effects. But due to disease-related factors like lethargy, physical activity is far too rarely implemented. Therefore EMS-whole-body-workouts could provide an opportunity to generate positive psychological effects through a less (subjective) cost-intense strength training.

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10117
        • Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject familiarized with experimental procedure and had given written informed consent
  • Depression, according to ICD-10
  • BDI-II Score ≥ 14
  • Able to understand German
  • Reachability of participant for the two training sessions

Exclusion Criteria:

  • Contraindications for physical exercise
  • Contraindications for EMS-use
  • Current EMS-use
  • Pregnancy
  • Borderline personality disorder
  • Bipolar Disorder
  • Schizophrenia
  • Anorexia Nervosa, Bulimia Nervosa
  • Dementia
  • Acute suicidality
  • Substance dependencies with actual consumption (except nicotine)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental-Condition

20 minutes whole-body-workout with simultaneous muscle stimulation (EMS).

Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout the muscles are simultaneously stimulated by those external electrodes with medium level (5) of stimulation intensity.

20 minutes whole-body-workout
Electromyostimulation-intensity 5 (muscle stimulation)
Placebo Comparator: Placebo-Condition

20 minutes whole-body-workout without simultaneous muscle stimulation (EMS).

Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout they are stimulated with the lowest possible stimulation intensity (1). This is perceptible as a slight tingling sensation but the impulse intensity lies below the muscular threshold and therefore generates no muscular activity.

20 minutes whole-body-workout
Electromyostimulation-intensity 1 (no muscle stimulation)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depressive symptoms
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Depressive symptoms are measured using the State-Scale of the State-Trait Depression Scales (STDS) by Spaderna, Schmukle & Krohne (2002). The SDTS State-Scale has two subscales with each 5 likert scaled items with values ranging from 1 to 4. Higher scores mean a worse outcome for the first subscale and a better outcome for the second subscale.
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety symptoms
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Anxiety symptoms are measured using the the State-Scale of the State-Trait Anxiety Inventory (STAI) by Laux, Glanzmann, Schaffner & Spielberger (1981). The STAI State-Scale has 20 likert scaled items with values ranging from 1 to 4, higher scores mean a worse outcome.
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Change in general self-efficacy
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
General self-efficacy is measured using the General-Self-Efficacy Scale (GSE) by Jerusalem & Schwarzer (1981). The GSE has 10 likert scaled items with values ranging from 1 to 4, higher scores mean a better outcome.
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Change in intention for physical activity
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Intention for physical activity is measured using two likert scaled items by Petzold et al. (2017). Values ranging from 1 to 4, higher scores mean a better outcome.
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Change in self-efficacy regarding physical activity
Time Frame: From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session
Self-efficacy is measured using two likert scaled items by Petzold et al. (2017). Values ranging from 1 to 4, higher scores mean a better outcome.
From directly before the intervention to immediately after the intervention - both: before/after the EMS-training-session and before/after the Placebo-session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Andreas Ströhle, Prof.Dr., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
  • Principal Investigator: Antonia Bendau, M.Sc.Psych., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2019

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

December 19, 2019

First Submitted That Met QC Criteria

December 21, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

August 2, 2021

Last Update Submitted That Met QC Criteria

July 27, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on whole-body-workout

3
Subscribe